chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient stated immediately after receiving flu vaccine in fall of 2005 and 11/06. She had right sided facial numbness lasting approximately 3 hours, then it subsided.
Fatigue,  weakness, dizziness,  leg pain,   head pain.   Had a fall on 3/23, not sure if it was due to the vaccine
ABOUT 36 HOURS AFTER THE VACCINES WERE GIVEN, PT WOKE UP FROM NAP AND HAD JERKING OF RIGHT ARM, TWITCHING /BLINKING OF EYES, LIP SMACKING. NO EYE DEVIATION. PT SEEMED ALERT AND RESPONSIVE. HE WENT TO THE ED. AFTER EVALUATION HERE HE WAS SENT TO HOSPITAL.
01/11/2021: Same day at 8 pm started to have body ache, headache, a little fever 100.1 and very tired. Took Tylenol.  Got up next day at 12:30 a lot better.  Today ok but not 100%.
This case was reported by a consumer via call center representative and described the occurrence of injection site pain in a adult male patient who received BOOSTRIX. In 2015, the patient received BOOSTRIX (injection). On an unknown date, an unknown time after receiving BOOSTRIX, the patient experienced injection site pain. On an unknown date, the outcome of the injection site pain was not recovered/not resolved. It was unknown if the reporter considered the injection site pain to be related to BOOSTRIX. Additional information received: The patient reported that he was given the BOOSTRIX vaccine in a doctor's office and he noticed that the nurse administered the vaccine with a very small needle and he is experiencing soreness in the arm that has continued for 5 weeks. The patient also has denied permission to contact their physician. Patient refused to provide any demographic information or any additional details regarding the adverse event reported.
Rash along neck and collar bone area, described as, "like goosebumps" by patient, and in two areas approximately 3 to 4 inches in length and 1.5 inches wide, each side of neck.  Described as painful to touch.  no difficulty breathing reported.  Occurred on 5/7/21, and two days after second dose.  Patient reported no unusual symptoms or reaction after the first dose was received.  Advised to monitor, and to go to urgent care or consult with primary care physician if symptoms did not improve, or if any difficulty breathing.  Attempted to call patient on 5/10/21 for follow up, and phone was disconnected after call number 1, and left a voice mail on second attempt.
GOT THE VACCINE AND DIED 24 HOURS LATER; This spontaneous report received from a consumer concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On an unspecified date, the patient died 24 hours later vaccination. Cause of death was not reported. It was unknown if an autopsy was performed. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. This report was serious (Death).; Sender's Comments: V0:20210350465-covid-19 vaccine ad26.cov2.s-Got the vaccine and died 24 hours later. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s); Reported Cause(s) of Death: UNKNOWN CAUSE OF DEATH
Might not be nothing, but I experienced the side effects from the first shot.  Chills, body ache, nausea and fatigue.  Most people say that should happen after the second shot.  I got the shot Friday and the symptoms started Monday.  The  symptoms went away in about 4 days before I felt good again.
Patient had several ED visits within 6 weeks of receiving COVID vaccination. Dates of service include: 3/4/21, 3/5/21, 3/15/21. He was admitted on 3/9/21 for one day.
Pt received Tdap on 9-18-13. Pt notified RN who administered the vaccine that within 24 hours. She experienced a fever of 101 with deep muscle and joint pain requiring 800 mg Ibuprofen. She reports that the muscle and joint pain has decreased. She denies muscle wasting. No fever as of 9-24-13.
Slight pain and swelling at injection site.  Body ache and slight nausea and exhaustion.  Worth noting that I was so excited about getting the vaccination that I could not sleep the night before.  I blame the exhaustion and later headache on lack of sleep, food, and caffeine.  I went to bed early and took acetaminophen and slept well.  In the morning a shower, coffee and breakfast and more acetaminophen makes me almost as good as new.
I ended up with shortness of breath beginning on April 9, 2021.  It got worse over the weekend and saw my PCP at 2pm on Monday April 12.  They sent me to the emergency room
Sick (injection site SHINGRIX site - looks good now/pt had violent shivering after SHINGRIX was given/pt was gardening last Wednesday) and Rash (arms, abdomen/itchy/pt had SHINGRIX last Friday - noticed rash on RUE - that afternoon, became blister on Sunday/other spots appeared on the R side of the abdomen/more spots noticed on LUE on Monday).
patient received Engerix-B first dose on May 16th 2023 and 2nd dose on Nov 13th 2023; This non-serious case was reported by a other health professional via call center representative and described the occurrence of drug dose administration interval too long in a 32-year-old female patient who received HBV (Engerix B) (batch number 9kg23, expiry date 10-FEB-2025) for prophylaxis.   Previously administered products included Engerix B (1st dose received on 16th May 2023).   On 13-NOV-2023, the patient received the 2nd dose of Engerix B. On 13-NOV-2023, an unknown time after receiving Engerix B, the patient experienced drug dose administration interval too long (Verbatim: patient received Engerix-B first dose on May 16th 2023 and 2nd dose on Nov 13th 2023). The outcome of the drug dose administration interval too long was unknown.   Additional Information: GSK Receipt Date:13-Nov-2023 The reporter was a pharmacy intern. The patient received 2nd dose of Engerix-B late than recommended time frame, which led to lengthening of vaccination schedule. The reporter asked if need to restart the series. The reporter did consent to follow up.
On 2/13 20 patient are became sore and she became tired after 2 hours of vaccine. the next day those symptoms were still present and she started to have body aches these symptoms lasted 24 hours.
Shingles presenting on V1 nerve.  Not experiencing stress or have a compromised immune system.
Nipples are very sore; My arm and armpits hurt; My arm and armpits hurt; High fevers all day; This spontaneous case was reported by a consumer and describes the occurrence of NIPPLE PAIN (Nipples are very sore), PAIN IN EXTREMITY (My arm and armpits hurt), AXILLARY PAIN (My arm and armpits hurt) and PYREXIA (High fevers all day) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced NIPPLE PAIN (Nipples are very sore), PAIN IN EXTREMITY (My arm and armpits hurt), AXILLARY PAIN (My arm and armpits hurt) and PYREXIA (High fevers all day). At the time of the report, NIPPLE PAIN (Nipples are very sore), PAIN IN EXTREMITY (My arm and armpits hurt), AXILLARY PAIN (My arm and armpits hurt) and PYREXIA (High fevers all day) outcome was unknown.            No concomitant medication information were provided. No treatment information were provided.   Reporter did not allow further contact
Within 15 seconds of injection, I felt my entire body buzzing and I got dizzy. I did not pass out but my body continued to buzz, especially around my heart and my extremities, for about 30-40 minutes.   I can't tell if it is related, but I continue to get heart flutters. I woke up in the middle of the night last night and couldn't catch my breath, which had never happened to me before.
Patient states the day after the shot she developed a rash on one leg and her ankle became swollen. She went to the urgent care and was given an antibiotic. They said it was not the flu shot but if gets worse, to go to dermatologist. Patient went to dermatologist today and she said she cannot rule out that it is not due to the flu shot. Patient has rash on both legs, arms (large red welts) and left foot is completely swollen. MD took biopsy and prescribed steroids and blood work.
Pt with history of allergies, resting in recovery area after vaccine at 1351, patient reported feeling mild itchy throat, gave 25 mg benedryl PO at 1415, RR 22, HR 80, patient reported various allergies and that she had an epipen at home that she had never used, patient also had eczema and face appeared red and blotchy, patient stated that her face is often red. Lung sounds clear bilaterally. Patient began to appear more red on face and throat, started with bronchospasms and coughing, swollen tongue, increased tightness, administered Epinephrine 0.3 mg left thigh (lot 026C20AA, Expiration 02/2022). Patient immediately experienced decrease in difficulty of breathing, redness and rash decreased on face and neck, EMS called, Patient transported to hospital via ambulance, mother to follow in car.
This spontaneous report was received from a registered nurse via company representative, concerning a female patient of unknown age. The patient's medical history and concurrent conditions were not reported. On an unknown date, the patient was vaccinated with a dose of GARDASIL 9 for prophylaxis (dose #, route of administration, lot # and expiration date were unknown). Concomitant medications were not reported. On an unknown date (reported as "later that same day"), the patient had passed out and had a seizure. The patient was taken to unspecified emergency room for treatment. At the time of reporting, the outcome of seizure and syncope was unknown. The causality assessment between the adverse events and GARDASIL 9 was not provided. Upon internal review, seizure was determined to be a medically significant event.
606 doses were given after expiration date; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (606 doses were given after expiration date) in a 37-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Oct-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (606 doses were given after expiration date). At the time of the report, EXPIRED PRODUCT ADMINISTERED (606 doses were given after expiration date) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were provided.  It was reported that the vial was initially stored in the refrigerator on 31-Oct-2021. Patient did not experience any adverse event. Vial did not undergo temperature excursions. No treatment medications were provided.
This spontaneous report was received from a medical assistance, refers to an unspecified numbers of patient of unknown age and gender. On unspecified dates, the unspecified number of patients were vaccinated with an improperly stored dose of VAQTA, lot # L018499, expiration date on 25-FEB-2017, lot # K005323, expiration date 10-FEB-2017 (dose #, dose and route of administration were not provided). There was not concomitant medication reported. No adverse effects were reported. There was not a product quality complain involved. It was unknown if the patients sought medical attention. This is one of several reports received from the same reporter. Additional information has been requested.
SOB, cough, head ache,  lethargy lasting 7 days.  high fever 101-102* lasting 2 days
Per Mother patient stated she was starting to feel light headed after receiving vaccine and fainted. Mother grabbed patient and helped lower her to exam table. Patient alert and oriented when RN re-entered room. Patient states she was a little nervous for vaccine and felt weak but didn't know what happened and thought she was dreaming. Gave patient Sprite to drink, states she is beginning to feel better. Dr. notified and evaluated patient. Had patient lay on exam table and rest for 15 more minutes. Color returning. Mother driving patient home. Alert note added to patient's chart re: syncope w/ vaccines.
The patient came into the pharmacy the afternoon of his appointment stating that he believed it had been given too high by the immunizer. He still had his bandaid on, so I confirmed that it had been given too high. He states that he felt as if it were being given too high at the time of administration, that it hurt more than previous doses and that he was able to feel the liquid going into his arm, which he had never felt before with other immunizations. His arm is not hurting and he has poor range of motion. He was told to take ibuprofen/tylenol, to follow up with his doctor if it continued to hurt, and to call us back if anything else where to aspire.
Patient was given the incorrect vaccine. Instead of the regular Pfizer, patient was given the pediatric vaccine.
potassium was 5.5 from blood work results, elevated Potassium post Imovax use; Initial information received on 30-Jul-2020 regarding an unsolicited valid non-serious case from a physician.  This case involves female patient (unspecified age groups and age) who experienced an increase in potassium of about 5.5, reported from blood work results (blood potassium increased), while she received vaccine RABIES (HDC) VACCINE [IMOVAX RABIES].  The patient had no prior history.  The patient's past medical treatment, vaccination and family history were not provided.  It was not reported that the patient had concomitant medications.   The patient received two doses of suspect RABIES (HDC) VACCINE (lot number and expiration date for both the doses were not reported) via unknown route in unknown administration site for unknown indication on 20-Jul-2020 and 27-Jul-2020.  On 22-Jul-2020, the patient who had increase in potassium of about 5.5 (blood potassium increased), 2 days post RABIES (HDC) VACCINE administration.  Relevant laboratory test results included: Blood potassium - On 22-Jul-2020: 5.5; on 29-Jul-2020: 5.5; on 30-Jul-2020: 5.5 (units unspecified for all).  Final diagnosis was blood potassium increased.   It was not reported if the patient received a corrective treatment.  The outcome was reported as Unknown for the event blood potassium increased.  There will be no information on the batch number for this case.
Chest pressure, dizziness, vertigo, nausea, vomiting, extreme pain in joints, brain fog, migraine that has not gone away
She got her vaccine, she felt it go straight into the muscle.  She felt a little pain but not bad.  As the day progressed the site seemed to be OK.  Sometime during the night she woke up and had aches and pains, muscle aches and joint aches and low grade fever of 101 all day on Sunday 2/27/22.  She had a headache, her whole body was overly sensitive and could not touch her scalp and it was painful. She was kind of nauseous, not hungry, tried to drink a lot of fluids.  She finally ate something for dinner on Sunday, something light, eggs and toast and tasted so good and within 5 minutes of eating it had pains in her stomach, but held it down.   The aches, pains and overall fatigue like weakness and hard to walk.  She was finally able to go to sleep and woke up at 5:00 AM on 2/28/22 soaking wet and did feel a little better.  She changed, went back to bed and between 5-7 AM had to get up and change clothes 3 times.  She switched sides of bed and slept.  When she got up around 8:30 she was still was really tired.  She felt better, but kept the day off of work.  The aches and pains started to dissipate but was still tired.  The area was still warm to the touch and swollen a little bit red.  She put ice on it and kept moving it to break it up.  Eventually on Monday the aches and pains went away, but today she still has a headache, pain in her head, and area more itchy, but still hurts to the touch.  She rolled over on her shoulder in her sleep and still painful to the touch.     She called her doctor, but has not heard back from them.    She is still not 100%, and has a low grade headache.    The sensation when she got her shot the first time was much different than the 2nd shot.   She could tell right when she got the 2nd shot it right into her muscle/biceps.  Could feel the liquid going into the muscle, which she did not feel the first time.
Palpitations, dizziness, erythema and heat at site consistent with cellulitis, malaise
Hospital Course:    Patient is a 91 y.o. male patient with a history of hypertension, atrial fibrillation (on Eliquis), HFpEF (echo 8/29/2022 showed EF 56%), and recent lacunar stroke without residual motor deficits who presented to the ED complaining of persistent cough. Chest x-ray in the ED showed slight fluid and mild infiltrate concerning for pneumonia in the right lung base.  He was found to be COVID-positive. He was started on Vanco/cefepime for concern of HAP, on further evaluation presentation appeared more consistent with viral etiology and antibiotics were discontinued. Was started on remdesivir and steroids. He has been afebrile and was weaned from 1LNC to room air. Found stable for discharge on 11/17. AMPAC 15/17. Per discussion with family, preferred to go home with previously established PRIVATE for disposition. OP follow-up with PCP, stroke clinic, and urology.   Discharge Diagnoses: Acute hypoxemic respiratory failure COVID-pneumonia Cough Patient presented with productive cough since he left the hospital on 11/3/2022 Chest x-ray 11/13 showed slight fluid and mild infiltrate in the right lung base COVID positive 11/13/22, flu negative.MRSA nare swab positive Patient was hypoxic on admission, requiring 2 L nasal cannula.  He was not showing any signs of acute respiratory distress. Corrected with supplemental oxygen and has been weaned to room air.  -Remdesivir infusions and decadron given while inpatient, transitioned to oral prednisone taper at discharge
Pt had localized redness, warmth, swelling and pain at and around the injection site. Stated that it had gotten worse in the last 2 days since the vaccine and was experiencing some pain in her breast under the arm that was vaccinated. Pt will be seeing the MD on 2/2 and will speak with them about the issue.
Left arm (entire upper arm) edematous, warm to touch, Blotchy red patches- pt took BENADRYL.
Injection site hot; Itchy at injection site; Injection site red; Injection site swollen; This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of INJECTION SITE WARMTH (Injection site hot), INJECTION SITE PRURITUS (Itchy at injection site), INJECTION SITE ERYTHEMA (Injection site red) and INJECTION SITE SWELLING (Injection site swollen) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20-2a) for COVID-19 vaccination.     Concurrent medical conditions included No adverse event and No adverse event.    On 30-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Jan-2021, the patient experienced INJECTION SITE WARMTH (Injection site hot), INJECTION SITE PRURITUS (Itchy at injection site), INJECTION SITE ERYTHEMA (Injection site red) and INJECTION SITE SWELLING (Injection site swollen). At the time of the report, INJECTION SITE WARMTH (Injection site hot), INJECTION SITE PRURITUS (Itchy at injection site), INJECTION SITE ERYTHEMA (Injection site red) and INJECTION SITE SWELLING (Injection site swollen) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment or concomitant medications were reported.
anaphylaxis; This is a literature report for the following literature source(s). A patient (no qualifiers provided) received BNT162b2 (BNT162B2), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: ANAPHYLACTIC REACTION (medically significant), outcome "unknown", described as "anaphylaxis". In another study, anaphylaxis was confirmed after the first dose in 7 patients who received BNT-162b2 vaccine and 9 patients who received mRNA-1273 vaccine. The CDC had reported a rate of 2.5 cases per million doses.No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Based on temporal association, the causal relationship between BNT162B2 and the event, Anaphylactic reaction cannot be completely ruled out. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.,Linked Report(s) : US-PFIZER INC-202200681973 Same article/ drug/event and different patient:
Protracted generalized muscle pain - discomfort , fatigue  Decreased sensory innervation foot  Diagnosed with mild guillame barre / small fiber neuropathy
1 day p/vax pt devel redness @ the site of vax;1wk following vax inj site was hard & blister was forming;
arm sore; little fever; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 66 year-old female patient received bnt162b2 (BNT162B2), administration date 29Jan2021 (Lot number: EN9581) at the age of 66 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "hypertension" (ongoing), notes: Also family had history of Just normal hypertension; "Thyroid" (ongoing). Concomitant medication(s) included: LEVOTHYROXINE taken for thyroid disorder (ongoing); VALSARTAN taken for hypertension (ongoing).  The following information was reported: PAIN IN EXTREMITY (non-serious) with onset 29Jan2021, outcome "unknown", described as "arm sore"; PYREXIA (non-serious) with onset 29Jan2021, outcome "recovered" (2021), described as "little fever". Relevant laboratory tests and procedures are available in the appropriate section.  No follow-up attempts are possible. No further information is expected.
Bruised, red & knotted more than with previous vaccines. It was also warm to the touch.
Patient received her COVID-19 vaccine and twenty minutes after she complained of feeling hot and had a mild rash on her neck. 1125 VS 125/71, HR 65, 96% on RA. Pt given water. Patient stated her allergist told her to wait for 60 minutes after given the vaccine since she has a history of allergic reactions/hives to other medications. 1130 110/61 HR 62 97% on RA. 1135 115/62 HR 75 96% RA. Pt c/o dizziness. Instructed to take in deep breaths and drink some water. 1150 123/58 HR 63 98% RA. Denies dizziness. Mild rash still present on neck. 1205 124/57 HR 67 97% on RA. Patient states she feels stable to be discharged home. Ambulated to car with belongings without difficulty. Instructed patient on what signs of adverse reaction to watch for and when to call 911.
I had flu like symptoms like sore throat, light fever, body aches and fatigue. I had a telehealth appointment with my provider.